Keuangan HCA Healthcare (HCA)
NYSE · Healthcare · Medical - Care Facilities · Karyawan: 320.000 · CEO: Samuel N. Hazen
- Harga
- $473,19 -1,02%
- Kapitalisasi pasar
- $102 M
- Nilai perusahaan
- $154 M
- Laporan terakhir
- Q3 '26 diajukan 2026-10-29
- Laporan berikutnya
- 2027-01-26 Estimasi EPS: $8,15
Pendapatan (TTM)$78,7 M+5,8% vs tahun lalu4 kuartal terakhir; batang = tiap kuartal
Margin operasional (TTM)15,3%-0,3 poin vs tahun laluLaba operasional: $12,1 M
Laba bersih (TTM)$6,78 M+6,8% vs tahun laluSetelah pajak, termasuk keuntungan non-operasional
Arus kas bebas (TTM)$5,97 M-26,2% vs tahun laluCapex: $5,2 M
EPS dilusian (TTM)$30,18+16,7% vs tahun laluJumlah 4 kuartal terakhir
Kas neto-$51,5 M-13,6% vs tahun laluKas + investasi jangka pendek - utang
Valuasi & angka utama
- Kapitalisasi pasar
- $102 M EV $154 M
- Pendapatan
- $78,7 M 12 bulan terakhir
- Pertumbuhan pendapatan
- +5% Konsensus FY2026
- Margin laba
- 8,6% Laba bersih / pendapatan, TTM
- P/E
- 57,4× Forward 15,8× (FY2026)
- P/S
- 1,3× Harga / penjualan, TTM
- EV / EBITDA
- 9,7× TTM
- Arus kas bebas
- $5,97 M 12 bulan terakhir
- Laba bersih
- $6,78 M 12 bulan terakhir
- Estimasi pendapatan
- $79,1 M Konsensus FY2026
- Laba
- 2027-01-26 Estimasi pendapatan: $20 M
- Dividen
- $3,06 Per saham, 12 bulan terakhir
Poin-poin utama
Dihitung dari angka yang dilaporkan - setiap pernyataan menyertakan angka yang mendasarinya.
- Laporan terakhir (2026-10-27): pendapatan melampaui 2,7%, EPS melampaui 8,6%Pendapatan $19,8 M vs $19,3 M yang diharapkan (+2,7%); EPS $7,22 vs $6,65 (+8,6%).
- Pertumbuhan pendapatan melambat: 3,6% yoyPendapatan Q3 '26: $19,8 M, rata-rata empat kuartal sebelumnya: 7,3%.
- Margin operasional 15,3% (TTM), dibanding tahun lalu: -0,3 poinLaba operasional tumbuh 3,8%, pendapatan tumbuh 5,8%.
- 22,9% dari laba sebelum pajak tergerus kerugian non-operasionalLaba sebelum pajak $9,82 M vs laba operasional $12,1 M (TTM). Kerugian dari kepemilikan saham dan pos sekali-pakai lainnya menekan laba bersih dan EPS - laba operasional adalah ukuran bisnis yang lebih bersih.
- Capex: 6,6% dari pendapatan (tahun lalu 6,4%)$5,2 M diinvestasikan dalam 4 kuartal terakhir (+9,6% dibanding tahun sebelumnya). Arus kas bebas: $5,97 M = 88,1% dari laba bersih.
- $9,84 M dikembalikan ke pemegang saham = 164,8% dari arus kas bebasBuyback: $9,16 M (tahun lalu $9,21 M), dividen: $681 jt, kompensasi saham: $0 (TTM). Lebih besar dari arus kas bebas: dibayar dari kas atau utang.
- Jumlah saham dilusian turun dalam setahun: 10,4%Saham dilusian pada Q3 '26: 217 jt, setahun sebelumnya: 242 jt.
- Utang neto: $51,5 MKas + investasi jangka pendek: $908 jt, utang termasuk sewa: $52,4 M; tahun lalu utang neto: $45,4 M.
Kuartal terakhir: Q3 '26
Kuartal berakhir 2026-09-30. Dibandingkan dengan kuartal yang sama tahun lalu dan konsensus analis sebelum laporan.
Kuartal vs tahun lalu
| Q3 '26 | Tahun lalu | Perubahan | |
|---|---|---|---|
| Pendapatan | $19,8 M | $19,2 M | +3,6% |
| Margin kotor | 14,9% | 41,8% | -26,9 poin |
| Laba operasional | $2,96 M | $2,97 M | 0,0% |
| Margin operasional | 14,9% | 15,5% | -0,5 poin |
| Laba bersih | $1,58 M | $1,64 M | -3,9% |
| EPS dilusian | $7,27 | $6,96 | +4,5% |
| Arus kas operasional | $4,46 M | $4,42 M | +1,0% |
| Capex | $1,36 M | $1,29 M | +5,4% |
| Arus kas bebas | $3,1 M | $3,13 M | -0,8% |
| R&D | $0 | $0 | – |
| Kompensasi berbasis saham | $0 | $0 | – |
Dilaporkan vs konsensus
2026-10-27| Aktual | Konsensus | vs konsensus | |
|---|---|---|---|
| Pendapatan | $19,8 M | $19,3 M | +2,7% |
| EPS (basis konsensus) | $7,22 | $6,65 | +8,6% |
Dari laporan 2026-10-27 untuk Q3 '26: pendapatan dan EPS yang diperkirakan analis (sering disesuaikan), sehingga bisa berbeda dari EPS laporan keuangan di atas.
EPS vs konsensus
8 laporan terakhirPendapatan
Dari mana uang berasal - menurut lini bisnis dan wilayah, kuartal demi kuartal.
Pendapatan, laba operasional, dan pertumbuhan
kuartalanPendapatan per lini bisnis
bertumpuk, kuartalan| Segmen | Q3 '26 | yoy | Porsi | TTM | TTM yoy | 12 kuartal |
|---|---|---|---|---|---|---|
| Managed Care And Other Insurers | $9,57 M | +3,3% | 49,7% | $37,2 M | +1,1% | |
| Managed Medicare | $3,53 M | +6,8% | 18,3% | $13,9 M | +6,8% | |
| Medicare | $2,93 M | +7,2% | 15,2% | $11,8 M | +5,3% | |
| Medicaid | $1,77 M | -1,0% | 9,2% | $7,49 M | +29,8% | |
| Managed Medicaid | $961 jt | +1,3% | 5,0% | $3,86 M | +5,4% | |
| International | $492 jt | +1,7% | 2,6% | $1,96 M | +7,5% |
Pendapatan per wilayah
porsi dari total| Segmen | Q3 '26 | yoy | Porsi | TTM | TTM yoy | 12 kuartal |
|---|---|---|---|---|---|---|
| Atlantic Group | $6,42 M | +4,5% | 33,8% | $26,6 M | +8,1% | |
| American Group | $6,85 M | +2,4% | 36,0% | $26,9 M | +2,8% | |
| National Group | $5,74 M | +3,9% | 30,2% | $21,8 M | +4,3% |
Margin & struktur biaya
Berapa bagian dari setiap unit pendapatan yang tersisa di tiap tingkat - dan ke mana biaya mengalir.
Margin
kuartalanBiaya sebagai % pendapatan
kuartalanArus kas & alokasi modal
Kas yang dihasilkan, untuk apa kas itu digunakan, dan apa yang sampai ke pemegang saham.
Arus kas operasional, capex, arus kas bebas
kuartalanPenggunaan kas vs arus kas operasional
tahun fiskal4 kuartal terakhir
laporan arus kas- Arus kas operasional
- $11,2 M
- Capex
- -$5,2 M
- Buyback
- -$9,16 M
- Dividen
- -$681 jt
- Akuisisi
- -$779 jt
- Utang neto diterbitkan
- $5,73 M
- Kompensasi berbasis saham
- $0
- Arus kas bebas
- $5,97 M
- Dikembalikan ke pemegang saham / FCF
- 164,8%
Jumlah saham dan EPS
kuartalan, dilusianNeraca
Likuiditas, investasi, dan utang pada akhir setiap kuartal.
Kas, investasi, dan utang
akhir kuartalValuasi & imbal hasil
Multiple saat ini dibandingkan lima tahun fiskal terakhir perusahaan itu sendiri; target dan peringkat analis.
Multiple dan imbal hasil
TTM vs 5 tahun fiskal| Sekarang | Rata-rata 5 th | Posisi saat ini dalam rentang 5 tahun | |
|---|---|---|---|
| P/E (TTM) | 57,4× | 13,6× | 11,9× – 16,3× |
| EV / EBITDA | 9,7× | 8,9× | 8,2× – 10,1× |
| EV / Penjualan | 2,0× | 1,9× | 1,7× – 2,1× |
| Harga / FCF | 17,2× | 15,2× | 13,8× – 16,9× |
| Harga / Nilai buku | -13,0× | – | – |
| Imbal hasil FCF | 5,8% | 6,6% | 5,9% – 7,3% |
| Imbal hasil modal yang diinvestasikan | 18,5% | 17,3% | 16,4% – 18,5% |
| Imbal hasil ekuitas | -100,5% | -317,6% | -745,6% – -112,6% |
Analis
Target konsensus $463,12 (-2,1%)
rentang $369,00 – $579,00 · peringkat Buy
Beli kuat0
Beli29
Tahan15
Jual2
Jual kuat0
Prospek
Konsensus analis untuk tahun fiskal mendatang dan implikasinya pada harga saat ini.
Estimasi konsensus
| Tahun fiskal | Pendapatan | Pertumbuhan | EPS | Pertumbuhan | P/E pada harga saat ini | Analis (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $79,1 M | +4,6% | $30,02 | +5,8% | 15,8× | 14 |
| FY2027 | $81,6 M | +3,2% | $31,35 | +4,4% | 15,1× | 16 |
| FY2028 | $85,3 M | +4,5% | $34,92 | +11,4% | 13,6× | 12 |
| FY2029 | $90,9 M | +6,6% | $39,12 | +12,0% | 12,1× | 9 |
| FY2030 | $96,3 M | +6,0% | $44,62 | +14,1% | 10,6× | 5 |
Laporan keuangan
Setiap baris laporan laba rugi, neraca, dan laporan arus kas - 12 kuartal dan 10 tahun fiskal, sebagai nilai, % pendapatan, atau pertumbuhan.
Semua pos yang dilaporkan
Semua 237 angka yang ditandai HCA Healthcare, Inc. dalam laporan 10-Q / 10-K terbarunya, dengan label dan definisi resmi SEC - termasuk catatan (sewa, pajak, buyback, karyawan, ...).
| Pos (label SEC) | Kuartal terakhir | Tahun lalu | yoy | FY terakhir | FY sebelumnya | yoy |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $5,1 M | $4,55 M | +12,1% | $4,66 M | $4,28 M | +9,0% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $11,5 M | $10,4 M | +10,4% | $10,9 M | $10,8 M | +1,1% |
| Accrual for Taxes Other than Income Taxes, Current | $504 jt2025-12-31 | $419 jt | +20,3% | $504 jt | $419 jt | +20,3% |
| Accrued Employee Benefits, Current | $216 jt2025-12-31 | $206 jt | +4,9% | $216 jt | $206 jt | +4,9% |
| Accrued Salaries, Current | $2,37 M | $2,29 M | +3,4% | $2,53 M | $2,3 M | +9,6% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $37,4 M | $34,9 M | +7,0% | $35,1 M | $33,1 M | +6,1% |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax | $5 jt | -$13 jt | +138,5% | $5 jt | -$13 jt | +138,5% |
| Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax | -$335 jt | -$292 jt | -14,7% | -$299 jt | -$353 jt | +15,3% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$350 jt | -$317 jt | -10,4% | -$305 jt | -$387 jt | +21,2% |
| Amortization of Debt Issuance Costs | – | – | – | $44 jt | $35 jt | +25,7% |
| Amortization of Debt Issuance Costs and Discounts | $11 jt | $7 jt | +57,1% | $44 jt | $35 jt | +25,7% |
| Amortization of Intangible Assets | – | – | – | $12 jt | $16 jt | -25,0% |
| AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax | -$20 jt | -$12 jt | -66,7% | -$11 jt | -$21 jt | +47,6% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $173 jt | $123 jt | +40,7% | – | – | – |
| Assets | $63,5 M | $59,7 M | +6,2% | $60,7 M | $59,5 M | +2,0% |
| Assets, Current | $16,2 M | $15,3 M | +6,1% | $15,8 M | $16,4 M | -3,8% |
| Buildings and Improvements, Gross | $23,7 M2025-12-31 | $22,7 M | +4,6% | $23,7 M | $22,7 M | +4,6% |
| Cash and Cash Equivalents, at Carrying Value | $908 jt | $997 jt | -8,9% | $1,04 M | $1,93 M | -46,2% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $908 jt | $997 jt | -8,9% | $1,04 M | $1,93 M | -46,2% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -$105 jt | $58 jt | -281,0% | -$893 jt | $998 jt | -189,5% |
| Common Stock, Dividends, Per Share, Declared | $0,78 | $0,72 | +8,3% | $2,88 | $2,64 | +9,1% |
| Common Stock, Par or Stated Value Per Share | $0,01 | $0,01 | 0,0% | $0,01 | $0,01 | 0,0% |
| Common Stock, Shares Authorized | 1,8 M | 1,8 M | 0,0% | 1,8 M | 1,8 M | 0,0% |
| Common Stock, Shares, Outstanding | 211 jt | 230 jt | -8,3% | 225 jt | 250 jt | -10,2% |
| Common Stock, Value, Outstanding | $2 jt | $2 jt | 0,0% | $2 jt | $3 jt | -33,3% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | $270 jt | $260 jt | +3,8% | $998 jt | $897 jt | +11,3% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $1,56 M | $1,64 M | -4,4% | $6,87 M | $5,8 M | +18,4% |
| Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | $1,83 M | $1,9 M | -3,3% | $7,86 M | $6,7 M | +17,5% |
| Construction in Progress, Gross | $2,15 M2025-12-31 | $1,86 M | +15,4% | $2,15 M | $1,86 M | +15,4% |
| Costs and Expenses | $17,5 M | $16,7 M | +4,4% | $65,8 M | $62,1 M | +5,9% |
| Current Federal Tax Expense (Benefit) | – | – | – | $1,55 M | $1,2 M | +29,0% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $13 jt | $20 jt | -35,0% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $248 jt | $212 jt | +17,0% |
| Debt Issuance Costs, Net | $439 jt | $416 jt | +5,5% | $436 jt | $369 jt | +18,2% |
| Debt Issuance Costs, Noncurrent, Net | $439 jt | $416 jt | +5,5% | $436 jt | $369 jt | +18,2% |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 | $68 jt | $60 jt | +13,3% | $57 jt | $65 jt | -12,3% |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 | $91 jt | $114 jt | -20,2% | $111 jt | $147 jt | -24,5% |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | $147 jt | $151 jt | -2,6% | $145 jt | $145 jt | 0,0% |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | $36 jt | $18 jt | +100,0% | $29 jt | $31 jt | -6,5% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 | $63 jt | $57 jt | +10,5% | $55 jt | $60 jt | -8,3% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 | $82 jt | $107 jt | -23,4% | $104 jt | $130 jt | -20,0% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | $136 jt | $147 jt | -7,5% | $140 jt | $140 jt | 0,0% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | $36 jt | $17 jt | +111,8% | $29 jt | $31 jt | -6,5% |
| Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value | $317 jt | $328 jt | -3,4% | $328 jt | $361 jt | -9,1% |
| Debt Securities, Available-for-sale, Noncurrent | $463 jt | $573 jt | -19,2% | $485 jt | $569 jt | -14,8% |
| Debt, Current | $8,09 M | $6,11 M | +32,5% | $4,89 M | $4,7 M | +4,1% |
| Debt, Long-term and Short-term, Combined Amount | $50,5 M | $44,5 M | +13,4% | $46,5 M | $43 M | +8,0% |
| DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss | $342 jt | $343 jt | -0,3% | $342 jt | $388 jt | -11,9% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | $201 jt | $394 jt | -49,0% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $6 jt | $7 jt | -14,3% |
| Deferred Income Taxes and Tax Credits | -$171 jt | $434 jt | -139,4% | $310 jt | $22 jt | +1.309,1% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | $31 jt | $31 jt | 0,0% |
| Deferred Tax Assets, Net of Valuation Allowance | $1,93 M2025-12-31 | $1,87 M | +3,2% | $1,93 M | $1,87 M | +3,2% |
| Deferred Tax Assets, Operating Loss Carryforwards, State and Local | $24 jt2025-12-31 | $167 jt | -85,6% | $24 jt | $167 jt | -85,6% |
| Deferred Tax Assets, Other | $268 jt2025-12-31 | $297 jt | -9,8% | $268 jt | $297 jt | -9,8% |
| Deferred Tax Assets, Property, Plant and Equipment | $02025-12-31 | $0 | – | $0 | $0 | – |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | $322 jt2025-12-31 | $285 jt | +13,0% | $322 jt | $285 jt | +13,0% |
| Deferred Tax Liabilities, Gross | $2,85 M2025-12-31 | $2,53 M | +12,6% | $2,85 M | $2,53 M | +12,6% |
| Deferred Tax Liabilities, Other | $1,04 M2025-12-31 | $932 jt | +11,2% | $1,04 M | $932 jt | +11,2% |
| Deferred Tax Liabilities, Property, Plant and Equipment | $1,36 M2025-12-31 | $1,14 M | +19,1% | $1,36 M | $1,14 M | +19,1% |
Sumber: SEC companyfacts (XBRL setiap 10-Q / 10-K). Kuartal arus kas dihitung dari angka kumulatif tahun berjalan yang ditandai dalam 10-Q. Rincian segmen ditandai dengan dimensi dan ditampilkan di bagian segmen.
Sumber
Laporan keuangan, pendapatan segmen, metrik, estimasi: Financial Modeling Prep. Laba segmen dan setiap pos yang dilaporkan: SEC EDGAR (XBRL). Laporan yang dibaca: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data per 2026-11-01